sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Remember me
INVESTORS
My Home
Small Cap Marketplace
Broadcast Center
Request New Hub
Quick Tips
Ratings & Ranks
PUBLIC COMPANIES
Investor Relations
Success Stories
Clients
Testimonials
Contact
Conferences
About us
A revenue-generating, small-cap Canadian pharmaceutical company
Revenue Projected at $150,000,000 by 2025
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Message Title
Rating
Author / Date
Re: VIDEO – Valeo Pharma Blood Thinner Approval Projected To Thicken Revenues By $30 MILLION Per Year (Not A Typo)
kooter33
Dec 26, 2020 10:51AM
Digital Investor Awareness Program-VPH
1
kooter33
Dec 09, 2020 01:05PM
New Message
Log in to Agoracom
Sign in with Facebook
Sign in with Linkedin
Remember me